Search Results

There are 2143 results for: content related to: The Pharmacology and Therapeutic Use of Dabigatran Etexilate

  1. Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 11, November 2008, Pages: 1354–1373, Dr. Brooke E. Baetz and Dr. Sarah A. Spinler

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.11.1354

  2. You have free access to this content
    A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 599–609, Paul K. L. Chin, Daniel F. B. Wright, David M. Patterson, Matthew P. Doogue and Evan J. Begg

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12364

  3. Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation

    Journal of the American Association of Nurse Practitioners

    Volume 27, Issue 4, April 2015, Pages: 190–196, Katie A. Scott and Karen A. Amirehsani

    Version of Record online : 25 JUL 2014, DOI: 10.1002/2327-6924.12161

  4. New Anticoagulants for Prevention of Stroke in Patients with Atrial Fibrillation

    Journal of Cardiovascular Electrophysiology

    Volume 22, Issue 8, August 2011, Pages: 948–955, JUAN F. VILES-GONZALEZ, VALENTIN FUSTER and JONATHAN L. HALPERIN

    Version of Record online : 10 JUN 2011, DOI: 10.1111/j.1540-8167.2011.02104.x

  5. Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 555–565, Dr Joachim Stangier, Dr Bengt I. Eriksson, Dr Ola E. Dahl, Dr Lennart Ahnfelt, Dr Gerhard Nehmiz, Hildegard Stähle, Dr Karin Rathgen and Dr Robbyna Svärd

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005274550

  6. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 243–250, Dr Joachim Stangier, Ms Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth, Dr Kathrin Reseski and Dr Thomas Körnicke

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010393342

  7. Dabigatran Etexilate in Clinical Practice: Confronting Challenges to Improve Safety and Effectiveness

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 12, December 2011, Pages: 1232–1249, Dr. Michael P. Gulseth, Dr. Ann K. Wittkowsky, Mr. John Fanikos, Dr. Sarah A. Spinler, Dr. William E. Dager and Dr. Edith A. Nutescu

    Version of Record online : 20 JAN 2012, DOI: 10.1592/phco.31.12.1232

  8. You have free access to this content
    Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

    Journal of Thrombosis and Haemostasis

    Volume 2, Issue 9, September 2004, Pages: 1573–1580, B. I. Eriksson, O. E. Dahl, L. Ahnfelt, P. Kälebo, J. Stangier, G. Nehmiz, K. Hermansson and V. Kohlbrenner

    Version of Record online : 10 AUG 2004, DOI: 10.1111/j.1538-7836.2004.00890.x

  9. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S2, June 2015, Pages: 1–997,

    Version of Record online : 3 JUN 2015, DOI: 10.1111/jth.12993

  10. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment

    The Journal of Clinical Pharmacology

    Volume 48, Issue 12, December 2008, Pages: 1411–1419, Dr Joachim Stangier, Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth and Dr Kasra Shakeri-Nejad

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008324179

  11. Rash Associated with Dabigatran Etexilate

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 3, March 2013, Pages: e23–e27, Kim To, Carl Reynolds and Sarah A. Spinler

    Version of Record online : 11 FEB 2013, DOI: 10.1002/phar.1203

  12. Dabigatran etexilate: What do hospitalists need to know?

    Journal of Hospital Medicine

    Volume 7, Issue 3, March 2012, Pages: 262–269, Amer Zeidan, Bishoy Faltas and Michael Streiff

    Version of Record online : 29 NOV 2011, DOI: 10.1002/jhm.996

  13. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  14. You have free access to this content
    Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 630–638, Paul K. L. Chin, David M. Patterson, Mei Zhang, Berit P. Jensen, Daniel F. B. Wright, Murray L. Barclay and Evan J. Begg

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12366

  15. You have free access to this content
    REVIEW: Atrial Fibrillation and Dabigatran: Has the Time Come To Use New Anticoagulants?

    Cardiovascular Therapeutics

    Volume 28, Issue 5, October 2010, Pages: 295–301, Carlos Escobar, Vivencio Barrios and David Jimenez

    Version of Record online : 16 AUG 2010, DOI: 10.1111/j.1755-5922.2010.00216.x

  16. You have free access to this content
    New anticoagulants: how to deal with treatment failure and bleeding complications

    British Journal of Clinical Pharmacology

    Volume 72, Issue 4, October 2011, Pages: 593–603, Rashid S. Kazmi and Bashir A. Lwaleed

    Version of Record online : 9 SEP 2011, DOI: 10.1111/j.1365-2125.2011.04060.x

  17. You have free access to this content
    Acute Stroke Management in Patients Taking Dabigatran

    CNS Neuroscience & Therapeutics

    Volume 18, Issue 8, August 2012, Pages: 616–622, Raf Brouns, Robbert-Jan Van Hooff, Ann De Smedt, Maarten Moens, Sylvie De Raedt, Maarten Uyttenboogaart, Gert-Jan Luijckx, Kristin Jochmans and Jacques De Keyser

    Version of Record online : 25 APR 2012, DOI: 10.1111/j.1755-5949.2012.00329.x

  18. Hemopericardium in a Patient Treated with Dabigatran Etexilate

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 5, May 2012, Pages: e103–e107, Cassie A. Barton, Wesley D. McMillian, S. Sadi Raza and Ray E. Keller

    Version of Record online : 9 APR 2012, DOI: 10.1002/j.1875-9114.2012.01036.x

  19. New and Emerging Anticoagulant Therapy for Atrial Fibrillation and Acute Coronary Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 975–1016, Estella M. Davis, Kathleen A. Packard, Jon T. Knezevich and Jennifer A. Campbell

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.10.975

  20. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke

    Annals of Neurology

    Volume 71, Issue 5, May 2012, Pages: 624–633, Waltraud Pfeilschifter, Ferdinand Bohmann, Peter Baumgarten, Michel Mittelbronn, Josef Pfeilschifter, Edelgard Lindhoff-Last, Helmuth Steinmetz and Christian Foerch

    Version of Record online : 23 MAR 2012, DOI: 10.1002/ana.23558